Adjustment of Immunosuppressants to Facilitate Anti-COVID-19 Antibody Production after mRNA Vaccination in Liver Transplant Recipients

Adjustment of Immunosuppressants to Facilitate Anti-COVID-19 Antibody Production after mRNA Vaccination in Liver Transplant Recipients

Liver transplant recipients are immunocompromised and have low immunogenicity to produce antibodies in anti-COVID-19 vaccination. Whether immunosuppressant adjustment could facilitate anti-COVID-19 antibody production in anti-COVID-19 mRNA vaccination is undetermined. Our patients were informed to t...

Full description

Bibliographic Details
Main Authors: Wei-Chen Lee, Hao-Chien Hung, Jin-Chiao Lee, Chung-Guei Huang, Po-Wei Huang, Po-Wen Gu, Yu-Chao Wang, Chih-Hsien Cheng, Tsung-Han Wu, Chen-Fang Lee, Ting-Jung Wu, Hong-Shiue Chou, Kun-Ming Chan
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Viruses
Subjects:
COVID-19
vaccine
liver transplantation
Moderna mRNA-1273 vaccine
immunosuppressant
Online Access:https://www.mdpi.com/1999-4915/15/3/678

Internet

https://www.mdpi.com/1999-4915/15/3/678

Similar Items